Pasithea Therapeutics Stock Forecast

Buy or Hold candidate since Jul 02, 2026 Loss -29.29%

The Pasithea Therapeutics Corp. stock price fell by -27.84% on the last day (Monday, 13th Jul 2026) from $0.0097 to $0.0070. During the last trading day the stock fluctuated 74.29% from a day low at $0.0070 to a day high of $0.0122. The price has been going up and down for this period, and there has been a 6.06% gain for the last 2 weeks. Volume has increased on the last day by 312 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 312 shares were bought and sold for approximately $2.18 .

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -27.62% during the next 3 months and, with a 90% probability hold a price between $0.0018 and $0.0069 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

KTTAW Signals & Forecast

The Pasithea Therapeutics Corp. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.0089. On a fall, the stock will find some support from the long-term average at approximately $0.0068. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, July 02, 2026, and so far it has fallen -29.29%. Further fall is indicated until a new bottom pivot has been found. Pasithea Therapeutics Corp. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Pasithea Therapeutics Corp. stock

Pasithea Therapeutics Corp. finds support from accumulated volume at $0.0069 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0052 between high and low, or 74.29%. For the last week, the stock has had daily average volatility of 26.01%.

Our recommended stop-loss: $0.0067 (-5.00%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 6 days ago.)

Trading Expectations (KTTAW) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Pasithea Therapeutics Corp. to open at $0.0087, and during the day (based on 14 day Average True Range), to move between $0.0053 and $0.0087, which gives a possible trading interval of +/-$0.0034 (+/-64.51%) up or down from last closing price. If Pasithea Therapeutics Corp. takes out the full calculated possible swing range there will be an estimated 64.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.0069 (1.43%) than the resistance at $0.0072 (2.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Pasithea Therapeutics Corp. stock A Buy?

Pasithea Therapeutics Corp. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $0.0087 ( 24.76%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk